Pricing Log in Create free account
Friday 6 November 2026 Export ADUS’s income statement to Excel — free account

Addus HomeCare Corporation

ADUS Healthcare Medical Care Facilities

Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024.

Revenue
+7.02%
EPS
+24.2%
Free cash flow
−17.1%
Total debt
−85.4%

Quarter to September 2026, against a year earlier

124.42 2.39 −1.88%
Market cap
$2.4B
P/E
21.1×
Fwd P/E
20.3×
Dividend yield
—
F-score
7/9
Altman Z
5.17
Beneish M
−2.23
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 3.11
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell 2 — 18 1 1 2 1 — — — — —
Insider Ownership 0.89%

Capital & Financial Ratios $m

Size
Market Cap 2,370.00
Revenue ttm 1,501.84
Net income ttm 111.05
Free cash flow ttm 144.39
Net debt Q (76.56)
Valuation
P/E 21.09
Forward P/E 20.30
Price / sales 1.54
Forward P/S Powerpack
Price / FCF 16.05
Price / book 2.02
Financial health
Current ratio Q 1.64 (at or above 1.5: strong)
Debt / equity Q 0.02 (at or below 0.5: strong)
Interest coverage Q 58.73
Growth
Revenue growth Q +7.02% (above 0%: growing)
Operating income growth Q +20.89% (above 0%: growing)
EPS, this year +13.67%
EPS, next year A +7.87%
Revenue, next year A +7.13%
EPS, past 5 yrs +20.20% (at or above 15%: strong)
EPS, next 5 yrs A +9.07%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.5×, against a ten-year median of 1.5×; over the ten years it ranged from 0.6× in 2016 to 2.5× in 2020.
P/E against its own 10 years 9.46%
10-year low 10-year high
P/S against its own 10 years 50.97%
10-year low 10-year high
P/B against its own 10 years 23.73%
10-year low 10-year high
EV/Sales against its own 10 years 42.57%
10-year low 10-year high
EV/FCF against its own 10 years 26.56%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 65 99 82 98
Receivables 115 123 152 161
Inventory — — — —
Other — — — —
200 260 269 281
2023 2024 2025 Q'26
Payables 26 27 17 20
ST’ Debt — — — —
Other 6 11 12 12
145 156 149 171

Compound Annual Growth %

10y 5y 3y
Sales 15.50% 13.22% 14.36%
Cash Flow 39.12% 0.38% 1.99%
Earnings 23.50% 23.69% 27.73%
Book Value 22.58% 15.91% 19.65%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 1.78 Actual 1.83

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 1.71 1.77 Beat by 0.06
Q1 FY26 1.52 1.62 Beat by 0.10
Q2 FY26 1.69 1.73 Beat by 0.04
Q3 FY26 1.78 1.83 Beat by 0.05
Q4 FY26 1.91 — Reports 22 February 2027

EPS $

Mar Jun Sep Dec Year
’26 1.36 1.49 1.54 — —
’25 1.16 1.20 1.24 1.61 5.22
’24 0.97 1.10 1.10 1.07 4.23
’23 0.78 0.91 0.95 1.20 3.83
’22 0.53 0.70 0.71 0.91 2.84
’21 0.55 0.72 0.72 0.81 2.81
’20 0.54 0.43 0.57 0.53 2.08
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 364 377 388 — —
’25 338 349 362 373 1,423
’24 281 287 290 297 1,155
’23 252 260 271 276 1,059
’22 227 237 240 247 951
’21 205 218 217 225 864
’20 190 185 194 196 765
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 52 40 41 — —
’25 19 23 51 19 112
’24 39 19 49 10 116
’23 19 42 22 30 112
’22 6 57 18 24 105
’21 (18) 15 18 25 39
’20 20 30 22 36 109
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 51 39 41 — —
’25 17 21 49 16 104
’24 37 18 47 9 110
’23 18 41 19 25 103
’22 5 56 17 19 97
’21 (19) 14 16 24 35
’20 18 29 21 35 103
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.6
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 401 426 517 649 765 864 951 1,059 1,155 1,423 1,502 +15.1% 1,524 1,597 1,672 +5.5%
Gross margin, % 26.52 27.20 26.48 27.63 29.58 31.21 31.51 32.10 32.48 32.47 32.32 +5.9 pt
EBT 16 21 20 33 42 60 60 81 99 127 150 +25.8%
EBT margin, % 4.03 4.94 3.95 5.11 5.48 6.99 6.33 7.68 8.60 8.96 9.95 +4.9 pt
Net income 12 12 16 25 33 45 46 63 74 96 111 +25.8%
Per share, $
Per share, $ Revenue 35.51 37.14 42.88 46.96 49.04 54.93 59.97 66.18 67.89 78.80 0.00 +9.3%
Earnings 1.06 1.04 1.41 1.76 2.08 2.81 2.84 3.83 4.23 5.22 6.00 +19.4%
Cash flow (0.07) 4.60 2.76 0.87 7.02 2.51 6.63 7.02 6.85 6.18 0.00 n/m
Capex (0.15) 0.01 (0.44) (0.33) (0.44) (0.30) (0.52) (0.59) (0.35) (0.43) 0.00 +12.2%
Free cash flow (0.22) 4.61 2.31 0.54 6.58 2.21 6.10 6.43 6.49 5.75 0.00 n/m
Book value 13.97 15.37 22.28 34.42 33.26 36.50 39.94 44.18 57.07 60.12 0.00 +17.6%
Shares, m 11 11 12 14 16 16 16 16 17 18 18 +5.4%
Valuation, ×
Valuation, × P/E 34.10 34.89 47.80 52.74 56.57 33.40 34.84 24.28 29.56 20.61 21.09 36.9
P/S 1.01 0.97 1.58 2.07 2.39 1.70 1.66 1.41 1.85 1.36 1.54 1.6
P/B 2.57 2.33 3.05 2.82 3.52 2.56 2.49 2.11 2.20 1.79 2.02 2.5
EV/Sales 1.05 0.94 1.48 1.99 2.45 1.76 1.71 1.47 1.95 1.39 1.49 1.6
EV/FCF (162.61) 7.60 27.60 178.07 18.31 43.94 16.84 15.11 20.43 19.09 15.53 18.4
Cash, $m
Cash, $m Operating cash flow (1) 53 33 12 109 39 105 112 116 112 152 n/m
Capex (2) 0 (5) (5) (7) (5) (8) (9) (6) (8) (8) +18.2%
Free cash flow (2) 53 28 7 103 35 97 103 110 104 144 n/m
Balance, $m
Balance, $m Working capital 81 101 115 182 144 207 92 55 105 120 110 +4.4%
Net debt 17 (11) (53) (52) 50 52 52 59 120 39 (77) +9.8%
Shareholders’ equity 158 176 268 476 519 574 634 707 970 1,085 1,180 +23.9%
Returns, %
Returns, % ROA 5.85 4.77 5.30 5.13 4.33 4.90 4.88 6.37 6.04 6.73 7.73 +0.9 pt
ROIC 5.53 9.54 6.62 5.13 4.89 6.58 6.27 7.42 5.89 7.70 8.79 +2.2 pt
ROE 8.12 7.16 7.39 6.78 6.66 8.26 7.62 9.33 8.78 9.33 9.96 +1.2 pt
People
People Employees 23,070 26,097 33,153 33,238 35,139 31,915 33,182 34,846 49,703 50,659 — +9.1%
Revenue/emp, $m 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.03 — +5.5%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Addus HomeCare Corporation vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ACHC Acadia Healthcare Company, Inc. $3.2B — (loss-making) 34.4× +5.14% (above 0%: growing) −5.00% (below 0%: shrinking) +196.54% (above 0%: growing) 100.00% 0.00% Compare
SGRY Surgery Partners, Inc. $3.0B — (loss-making) — (loss-making) +2.75% (above 0%: growing) n/m −60.63% (below 0%: shrinking) 22.41% 12.78% Compare
AVAH Aveanna Healthcare Holdings Inc. $3.0B 10.5× 18.3× +13.73% (above 0%: growing) +46.15% (above 0%: growing) +57.89% (above 0%: growing) 32.59% 11.93% Compare
BKD Brookdale Senior Living Inc. $2.6B — (loss-making) 341× −11.61% (below 0%: shrinking) n/m +533.14% (above 0%: growing) 29.94% 11.86% Compare
GRDN Guardian Pharmacy Services, Inc. $2.5B 37.8× 33.3× −1.68% (below 0%: shrinking) +133.33% (above 0%: growing) +88.88% (above 0%: growing) 22.97% 6.75% Compare
MD Pediatrix Medical Group, Inc. $2.5B 17.1× 15.3× +1.72% (above 0%: growing) −27.61% (below 0%: shrinking) −14.41% (below 0%: shrinking) 27.98% 13.01% Compare
ADUS Addus HomeCare Corporation $2.4B 21.1× 20.3× +7.02% (above 0%: growing) +24.19% (above 0%: growing) −17.07% (below 0%: shrinking) 32.08% 10.27%
ASTH Astrana Health, Inc. $1.9B 46.8× 25.9× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53% Compare
AMN AMN Healthcare Services Inc $1.8B 17.4× 25.4× +2.29% (above 0%: growing) +117.88% (above 0%: growing) −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
Median of peers $2.6B 17.4× 25.9× +2.52% +78.34% +21.74% 28.96% 9.31%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 23 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 12.19m 11.98m 91.67
2024 5.55m 7.41m 107.01
2023 4.17m 3.95m 79.28
2022 3.74m 4.24m 84.96
2021 3.44m 1.72m 79.86

Ownership

Directors and executive officers, together 4.10%
BlackRock 14.20%
Capital Research Global Investors 7.90%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Addus HomeCare Corporation (ADUS) Latest News

4 Nov

Impact 4 · · The Motley Fool transcript
Impact 3 · · GuruFocus.com
Impact 3 · · MarketBeat transcript
Impact 3 · · Moby

3 Nov

Impact 4 · · Business Wire
Impact 3 · · Investing.com

30 Sep

Impact 3 · · Zacks

28 Sep

Impact 3 · · StockStory

23 Sep

Impact 4 · · Insider Monkey

15 Sep

Impact 4 ·

14 Sep

Impact 4 ·
Impact 4 ·
Impact 4 ·

5 Aug

Impact 3 ·

4 Aug

Impact 4 ·
Impact 3 · · MarketBeat transcript

3 Aug

Impact 3 ·
Impact 3 ·
Impact 3 ·

8 May

Impact 3 · · Insider Monkey

5 May

Impact 4 · · Simply Wall St.
Impact 4 · · MarketBeat
Impact 4 · · Moby
Impact 3 · · Simply Wall St.

4 May

Impact 4 · · Zacks
Impact 4 · · Zacks
Impact 4 · · Business Wire
Impact 3 · · StockStory

3 May

Impact 4 · · StockStory

25 Mar

Impact 4 · · Zacks

ADUS metrics, ten years each

stockrow.com/ADUS · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com